Paul Colgan
@paulcolgan.bsky.social
Award Winning Journalist and Broadcaster. Irish Politics and Economics.
The FT article also suggests a US reluctance to offer carve-outs on pharmaceuticals - which would leave the Irish pharma sector in line for significant tariffs.
Perhaps not Trump's threatened 200% - but not good nonetheless. 2/2
Perhaps not Trump's threatened 200% - but not good nonetheless. 2/2
July 9, 2025 at 12:22 PM
The FT article also suggests a US reluctance to offer carve-outs on pharmaceuticals - which would leave the Irish pharma sector in line for significant tariffs.
Perhaps not Trump's threatened 200% - but not good nonetheless. 2/2
Perhaps not Trump's threatened 200% - but not good nonetheless. 2/2